Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Eligibility criteria
Qualifiers
adult patients with suspected pneumocystis
with an indication for bronchial fibroscopy for BAL or induced sputum
no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition
Disqualifiers
Pneumocystis treated for more than 72 hours
pregnancy/breast-feeding
adult patients deprived of liberty, protected
Trial design
Treatments tested in this trial
- Biological sampling
Treatment groups
240 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov